Providence Cancer Center/Earle A. Chiles Res. Inst. — Portland, Oregon

Providence Cancer Center/Earle A. Chiles Res. Inst. is a clinical research site located in Portland, Oregon, United States 97213.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Providence Cancer Center/Earle A. Chiles Res. Inst. has participated in 1 clinical trials.

Therapeutic areas: Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell.

Sponsors: Juno Therapeutics, a Subsidiary of Celgene.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Cancer Center/Earle A. Chiles Res. Inst.?

Providence Cancer Center/Earle A. Chiles Res. Inst. has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Cancer Center/Earle A. Chiles Res. Inst. conducted?

Providence Cancer Center/Earle A. Chiles Res. Inst. has 1 clinical trials on record. Their work covers Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell.

Is Providence Cancer Center/Earle A. Chiles Res. Inst. accredited by Crixeo Health?

Providence Cancer Center/Earle A. Chiles Res. Inst. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Cancer Center/Earle A. Chiles Res. Inst.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.